» Articles » PMID: 7477448

Comparison of Corelease of Noradrenaline and ATP Evoked by Hypogastric Nerve Stimulation and Field Stimulation in Guinea-pig Vas Deferens

Overview
Specialty Pharmacology
Date 1995 Aug 1
PMID 7477448
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Contractions and overflow of tritium and ATP elicited by hypogastric nerve stimulation (HNS) and field stimulation (FS) were studied in the guinea-pig isolated vas deferens preincubated with [3H]-noradrenaline. ATP was measured by means of the luciferin-luciferase technique. HNS and FS elicited contraction, tritium overflow and ATP overflow. HNS at supramaximal current strength produced smaller responses than did FS at supramaximal current strength (210 pulses/7 Hz). Supramaximal HNS and submaximal FS were used in the remainder of the study. Prazosin (0.3 mumol/l) reduced contractions and the overflow of ATP elicited by both HNS and FS; the evoked overflow of tritium was not changed (210 pulses/7 Hz). Combined administration of prazosin (0.3 mumol/l) and suramin (300 mumol/l) abolished contractions and reduced the overflow of ATP elicited by both HNS and FS slightly more than did prazosin alone; tritium overflow again was not changed (210 pulses/7 Hz). Contractions, tritium overflow and ATP overflow increased with the frequency of both HNS and FS (from 7 to 25 Hz; 210 pulses); the increase in ATP overflow with frequency was more marked than the increase in tritium overflow. The preferential increase of ATP overflow with the frequency of HNS and FS persisted in the combined presence of prazosin (0.3 mumol/l) and suramin (300 mumol/l). The study confirms for HNS, a more physiologic way of sympathetic nerve stimulation, several observations previously obtained with FS. First, HNS-evoked ATP release is detectable as an overflow of ATP into the superfusion fluid.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine.

Jackson E, Zhang Y, Cheng D Hypertension. 2017; 69(3):484-493.

PMID: 28137984 PMC: 5310812. DOI: 10.1161/HYPERTENSIONAHA.116.08623.


Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional beta-adrenoceptors: evidence for the beta 2 subtype.

Driessen B, Bultmann R, Goncalves J, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(5):564-71.

PMID: 8740151 DOI: 10.1007/BF00169177.


Opposite modulation of cotransmitter release in guinea-pig vas deferens: increase of noradrenaline and decrease of ATP release by activation of prejunctional beta-adrenoceptors.

Goncalves J, Bultmann R, Driessen B Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(2):184-92.

PMID: 8717159 DOI: 10.1007/BF00168756.


Failure of tyramine to release neuronal ATP as a cotransmitter of noradrenaline in the guinea-pig vas deferens.

Driessen B, Goncalves J, Szabo B Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(2):175-83.

PMID: 8717158 DOI: 10.1007/BF00168755.

References
1.
Westfall D, Stitzel R, Rowe J . The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens. Eur J Pharmacol. 1978; 50(1):27-38. DOI: 10.1016/0014-2999(78)90250-9. View

2.
Ellis J, Burnstock G . Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens. Br J Pharmacol. 1989; 97(4):1157-64. PMC: 1854631. DOI: 10.1111/j.1476-5381.1989.tb12574.x. View

3.
Kurz A, Bultmann R, Driessen B, von Kugelgen I, Starke K . Release of ATP in rat vas deferens: origin and role of calcium. Naunyn Schmiedebergs Arch Pharmacol. 1994; 350(5):491-8. DOI: 10.1007/BF00173018. View

4.
Alberts P, Bartfai T, Stjarne L . Site(s) and ionic basis of alpha-autoinhibition and facilitation of "3H'noradrenaline secretion in guinea-pig vas deferens. J Physiol. 1981; 312:297-334. PMC: 1275555. DOI: 10.1113/jphysiol.1981.sp013630. View

5.
HEDLER L, Stamm G, Weitzell R, Starke K . Functional characterization of central alpha-adrenoceptors by yohimbine diastereomers. Eur J Pharmacol. 1981; 70(1):43-52. DOI: 10.1016/0014-2999(81)90430-1. View